Senate Republicans so far have presented three different versions of an Obamacare replacement bill. » Read More
By: Jennifer Fitzgerald, CEO and co-founder of PolicyGenius
Obamacare was a Republican idea in the first place. There is no other option, says Jennifer Fitzgerald. » Read More
By: Dylan Scott
Mitch McConnell is still trying to pass a health-care bill, leaning on these two arguments, Vox reports. » Read More
Trump's health care efforts failed to accomplish the 'art of the deal, because Trump made these 'rookie mistakes.'
Wall Street believes the biopharma's focus on developing treatments for rare neuromuscular diseases is paying off.
Collaborative relationships with hospitals across the globe are improving patient outcomes and operational efficiencies.
Credit Suisse believes Pfizer will suffer from the patent expirations of its key drugs such as Viagra and Lyrica.
Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms.
Presidents Trump and Obama made the same mistake, a former U.S. assistant secretary of Commerce tells CNBC.
Intel has eliminated its wearables product group, a source tells CNBC.
Jim Cramer broke down his strategy to why Snap fell out of his favor.
Obamacare won't collapse under its own weight — if it is done in, it will be because of Republicans, Mario Molina said.
The news comes after President Donald Trump pushed Republican senators to reach an agreement on a measure before the August recess.
The GOP health bill failure will hurt Republicans in Congress more than it will touch President Trump, says Jake Novak.
Despite reports of a “death spiral,” Obamacare is alive and well in many states. But the White House could try to weaken it.
As bad headlines fade and Vertex rises, biotechnology is on the upswing, says Jefferies' Michael Yee.
McConnell said Senate vote on a motion next week to move ahead with a bill to repeal and or replace Obamacare could easily be amended.
On health care, Trump is uninformed, underprepared, and unclear — and this is is the result, Vox reports.
Medical marijuana still faces many hurdles in the U.S. There's an even bigger market that is ripe for investment, says CEO Benjamin Ward.
Get the best of CNBC in your inbox